logo

Edible Bioactive Film with Curcumin

PDF Publication Title:

Edible Bioactive Film with Curcumin ( edible-bioactive-film-with-curcumin )

Previous Page View | Next Page View | Return to Search List

Text from PDF Page: 012

Int. J. Mol. Sci. 2022, 23, 5638 12 of 14 51. Elahi, M.; Heli, H.; Bathaie, S.; Mousavi, M. Electrocatalytic oxidation of glucose at a Ni-curcumin modified glassy carbon electrode. J. Solid State Electrochem. 2007, 11, 273–282. [CrossRef] 52. Halevas, E.; Arvanitidou, M.; Mavroidi, B.; Hatzidimitriou, A.; Politopoulos, K.; Alexandratou, E.; Pelecanou, M.; Sagnou, M. A novel curcumin gallium complex as photosensitizer in photodynamic therapy: Synthesis, structural and physicochemical characterization, photophysical properties and in vitro studies against breast cancer cells. J. Mol. Struct. 2021, 1240, 130485. [CrossRef] 53. Li, H.; Sureda, A.; Devkota, H.; Pittalà, V.; Barreca, D.; Silva, A.; Tewari, D.; Xu, S.; Nabavi, S. Curcumin, the golden spice in treating cardiovascular diseases. Biotechnol. Adv. 2020, 38, 107343. [CrossRef] 54. Malik, P.; Mukherjee, T. Structure-function elucidation of antioxidative and prooxidative activities of the polyphenolic compound curcumin. Chin. J. Biol. 2014, 2014, 396708. [CrossRef] 55. Priyadarsini, K.; Maity, D.; Naik, G.; Kumar, M.; Unnikrishnan, M.; Satav, J.; Mohan, H. Role of phenolic OH and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free. Radic. Biol. Med. 2003, 35, 475–484. [CrossRef] 56. Madreiter-Sokolowski, C.; Thomas, C.; Ristow, M. Interrelation between ROS and Ca2+ in aging and age-related diseases. Redox Biol. 2020, 36, 101678. [CrossRef] 57. Calabrese, E.; Kozumbo, W. The hormetic dose-response mechanism: Nrf2 activation. Pharmacol. Res. 2021, 167, 105526. [CrossRef] [PubMed] 58. Pandey, K.; Rizvi, S. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med. Cell. Longev. 2009, 2, 270–278. [CrossRef] [PubMed] 59. Zheng, D.; Huang, C.; Huang, H.; Zhao, Y.; Khan, M.; Zhao, H.; Huang, L. Antibacterial Mechanism of Curcumin: A Review. Chem. Biodivers. 2020, 17, e2000171. [CrossRef] [PubMed] 60. Makrantonaki, E.; Wlaschek, M.; Scharffetter-Kochanek, K. Pathogenesis of wound healing disorders in the elderly. JDDG J. Dtsch. Dermatol. Ges. 2017, 15, 255–275. [CrossRef] [PubMed] 61. Dairaku, I.; Han, Y.; Yanaka, N.; Kato, N. Inhibitory effect of curcumin on IMP dehydrogenase, the target for anticancer and antiviral chemotherapy agents. Biosci. Biotechnol. Biochem. 2010, 74, 185–187. [CrossRef] 62. Aggarwal, B.; Gupta, S.; Sung, B. Curcumin: An orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br. J. Pharmacol. 2013, 169, 1672–1692. [CrossRef] 63. WHO. Noncommunicable Diseases. Available online: https://www.who.int/news-room/fact-sheets/detail/noncommunicable- diseases (accessed on 20 January 2022). 64. Pourbagher-Shahri, A.; Farkhondeh, T.; Ashrafizadeh, M.; Talebi, M.; Samargahndian, S. Curcumin and cardiovascular diseases: Focus on cellular targets and cascades. Biomed. Pharmacother. 2021, 136, 111214. [CrossRef] 65. Hemshekhar, M.; Anaparti, V.; El-Gabalawy, H.; Mookherjee, N. A bioavailable form of curcumin, in combination with vitamin- D-and omega-3-enriched diet, modifies disease onset and outcomes in a murine model of collagen-induced arthritis. Arthritis Res. Ther. 2021, 23, 39. [CrossRef] [PubMed] 66. Akbari, M.; Lankarani, K.; Tabrizi, R.; Ghayour-Mobarhan, M.; Peymani, P.; Ferns, G.; Ghaderi, A.; Asemi, Z. The effects of curcumin on weight loss among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Front. Pharmacol. 2019, 10, 649. [CrossRef] [PubMed] 67. Safarian, H.; Parizadeh, S.; Saberi-Karimain, M.; Darroudi, S.; Javandoost, A.; Mohammadi, F.; Moammeri, M.; Ferns, G.; Ghayour-Mobarhan, M.; Mohebati, M. The effect of curcumin on serum copper and zinc and Zn/Cu ratio in individuals with metabolic syndrome: A double-blind clinical trial. J. Diet. Suppl. 2019, 16, 625–634. [CrossRef] [PubMed] 68. Pivari, F.; Mingione, A.; Brasacchio, C.; Soldati, L. Curcumin and type 2 diabetes mellitus: Prevention and treatment. Nutrients 2019, 11, 1837. [CrossRef] [PubMed] 69. Zheng, J.; Cheng, J.; Zheng, S.; Feng, Q.; Xiao, X. Curcumin, a polyphenolic curcuminoid with its protective effects and molecular mechanisms in diabetes and diabetic cardiomyopathy. Front. Pharmacol. 2018, 9, 472. [CrossRef] [PubMed] 70. Assis, R.; Arcaro, C.; Gutierres, V.; Oliveira, J.; Costa, P.; Baviera, A.; Brunetti, I. Combined effects of curcumin and lycopene or bixin in yoghurt on inhibition of LDL oxidation and increases in HDL and paraoxonase levels in streptozotocin-diabetic rats. Int. J. Mol. Sci. 2017, 18, 332. [CrossRef] 71. Jamilian, M.; Foroozanfard, F.; Kavossian, E.; Aghadavod, E.; Shafabakhsh, R.; Hoseini, A.; Asemi, Z. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Clin. Nutr. ESPEN 2020, 36, 128–133. [CrossRef] 72. Tomeh, M.; Hadianamrei, R.; Zhao, X. A review of curcumin and its derivatives as anticancer agents. Int. J. Mol. Sci. 2019, 20, 1033. [CrossRef] 73. CDC. Mental and Chronic Diseases. Available online: https://www.cdc.gov/chronicdisease/index.htm (accessed on 20 January 2022). 74. Ramaholimihaso, T.; Bouazzaoui, F.; Kaladjian, A. Curcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review. Front. Psychiatry 2020, 11, 572533. [CrossRef] 75. Vareed, S.; Kakarala, M.; Ruffin, M.; Crowell, J.; Normolle, D.; Djuric, Z.; Brenner, D. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol. Prev. Biomark. 2008, 17, 1411–1417. [CrossRef] 76. Dei Cas, M.; Ghidoni, R. Dietary curcumin: Correlation between bioavailability and health potential. Nutrients 2019, 11, 2147. [CrossRef] [PubMed]

PDF Image | Edible Bioactive Film with Curcumin

edible-bioactive-film-with-curcumin-012

PDF Search Title:

Edible Bioactive Film with Curcumin

Original File Name Searched:

ijms-23-05638.pdf

DIY PDF Search: Google It | Yahoo | Bing

CO2 Organic Rankine Cycle Experimenter Platform The supercritical CO2 phase change system is both a heat pump and organic rankine cycle which can be used for those purposes and as a supercritical extractor for advanced subcritical and supercritical extraction technology. Uses include producing nanoparticles, precious metal CO2 extraction, lithium battery recycling, and other applications... More Info

Heat Pumps CO2 ORC Heat Pump System Platform More Info

CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com | RSS | AMP